Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT03250299 · TERMINATED
Trial details
- NCT number
- NCT03250299
- Sponsor
- Basilea Pharmaceutica
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2022-06-03
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.